There is 1 version of this bill. View text

Click the check-box to add or remove the section, click the text link to scroll to that section.
Titles Actions Overview All Actions Cosponsors Committees Related Bills Subjects Latest Summary All Summaries

Titles (2)

Short Titles

Short Titles - House of Representatives

Short Titles as Introduced

Medicare Prescription Drug Savings and Choice Act of 2018

Official Titles

Official Titles - House of Representatives

Official Title as Introduced

To amend part D of title XVIII of the Social Security Act to deliver a meaningful benefit and lower prescription drug prices under the Medicare Program.


Actions Overview (1)

Date Actions Overview
07/26/2018Introduced in House

All Actions (5)

Date All Actions
08/13/2018Referred to the Subcommittee on Health.
Action By: Committee on Ways and Means
07/27/2018Referred to the Subcommittee on Health.
Action By: Committee on Energy and Commerce
07/26/2018Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Action By: House of Representatives
07/26/2018Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Action By: House of Representatives
07/26/2018Introduced in House
Action By: House of Representatives

Cosponsors (0)

No cosponsors.


Committees (2)

Committees, subcommittees and links to reports associated with this bill are listed here, as well as the nature and date of committee activity and Congressional report number.

Committee / Subcommittee Date Activity Reports
House Energy and Commerce07/26/2018 Referred to
House Energy and Commerce Subcommittee on Health07/27/2018 Referred to
House Ways and Means07/26/2018 Referred to
House Ways and Means Subcommittee on Health08/13/2018 Referred to

A related bill may be a companion measure, an identical bill, a procedurally-related measure, or one with text similarities. Bill relationships are identified by the House, the Senate, or CRS, and refer only to same-congress measures.


Latest Summary (1)

There is one summary for H.R.6575. View summaries

Shown Here:
Introduced in House (07/26/2018)

Medicare Prescription Drug Savings and Choice Act of 2018

This bill requires the Centers for Medicare & Medicaid Services (CMS) to offer one or more Medicare-operated prescription drug plan options under the Medicare prescription drug benefit.  In doing so, the CMS must: (1) negotiate prices with drug manufacturers; (2) establish an appeals process for denials of plan benefits, including the option for external review and determination by an independent entity; and (3) establish and apply a formulary and formulary incentives. In general, a Medicare-operated drug plan must meet the same requirements as apply to any other prescription drug plan.